CNAs remain least vaccinated, requiring ‘large-scale’ solution … AARP says Florida leads nation in COVID deaths of nursing home residents, staff … Hardware-free virtual physical therapy system...
Clinical briefs for Thursday, Sept. 16
By
Alicia Lasek
Sep 16, 2021
U.S. to limit states’ access to COVID antibody treatments as demand rises … Aggressively reducing Alzheimer’s risk factors could mean 1.2 million fewer cases in 2050: experts … NIH launches nationwide...
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
Clinical briefs for Monday, Aug. 23
By
Alicia Lasek
Aug 23, 2021
FDA pushing to fully approve Pfizer COVID vaccine this week … Accessible strength training nearly equals effect of drugs in lowering blood pressure, experts find … Need for yearly COVID shot may not...
Clinical briefs for Monday, June 28
By
Alicia Lasek
Jun 28, 2021
To save itself, Medicare could deny coverage of controversial new Alzheimer’s drug, expert predicts … Aduhelm most appropriate for early dementia, MCI, experts say … Eli Lilly to seek early approval...
Post-surgical delirium in frail, older adults may be caused by inflammation
By
Alicia Lasek
Apr 19, 2020
Inflammation can contribute to rapid beta-amyloid plaque buildup in the brain, disrupting mental status, finds a new study.
SNF-linked wound clinics saw fewer patients during pandemic but unchanged outcomes
By
Alicia Lasek
Nov 10, 2021
Investigators expected that wound outcomes would be adversely affected by pandemic disruptions. But data from hundreds of wound care clinics in the United States show otherwise.
Moderna’s COVID-19 vaccine spurs immune response in trial
By
Alicia Lasek
Jul 16, 2020
“No matter how you slice this, this is good news,” said Anthony Fauci, M.D., the U.S. government’s top infectious disease expert.
New antipsychotic improves symptoms minus side effects in trial
By
Alicia Lasek
Jan 10, 2020
Antipsychotic drug lumateperone improves schizophrenia symptoms without side effects such as weight gain and metabolic disturbance.
COVID-19 vaccine expected to be ready for year-end approval
By
Alicia Lasek
Jul 13, 2020
Pfizer Inc and BioNTech SE plan to seek federal approval for a jointly developed coronavirus vaccine by the end of 2020. The drugmakers say they have been ramping up production capabilities to meet expected...